NCT07044336

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-08-01Est. Completion: 2027-10-15

Enrollment target: 800 participants

Locations

Research Site, Tucson, Arizona, United States
Research Site, La Jolla, California, United States
Research Site, Los Angeles, California, United States
Research Site, Orange, California, United States
Research Site, Washington D.C., District of Columbia, United States
Research Site, Jupiter, Florida, United States
Research Site, Miami, Florida, United States
Research Site, Miami, Florida, United States
Research Site, Miami Beach, Florida, United States
Research Site, New Port Richey, Florida, United States
Research Site, Orlando, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, West Palm Beach, Florida, United States
Research Site, Honolulu, Hawaii, United States
Research Site, Chicago, Illinois, United States
Research Site, Peoria, Illinois, United States
Research Site, Urbana, Illinois, United States
Research Site, Fort Wayne, Indiana, United States

Other microbiome trials you might be interested in

SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial CancerPhase 4Recruiting

Endometrial CancerEndometrial Cancer Stage IAtypical Endometrial Hyperplasia and Endometrial Carcinoma Stage IAtypical Endometrial HyperplasiaEndometrial Intraepithelial NeoplasiaObesity & OverweightBMI>40ObesityObesity Grade III

SHAPE-ENDO is a single-center, open-label, pilot randomized clinical trial conducted at Hospital Universitari de Bellvit…

Multiple LocationsEst. completion Apr 2031

View Trial →

Laparotomy vs Laparoscopy in Endometrial Cancer StagingRecruiting

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.